Laboratory Developed Testing Global Industry Overview and Competitive Landscape till 2032

Owing to the high prevalence of chronic conditions & genetic disorders, rise in the incidence of infectious & autoimmune diseases, and increasing awareness among the population for a healthy life, the global laboratory developed test market is expanding and is currently valued of US$ 7.7 Bn.

Request For Free Sample Report of "Laboratory Developed Testing Market"@ https://www.persistencemarketresearch.com/samples/3430

Government and non-government organizations across the world are focused on spreading awareness about living a healthy lifestyle to reduce the prevalence of chronic disorders and prevent obesity & diabetes due to unhealthy diets. This is driving the development and adoption rate of laboratory developed tests, providing significant growth opportunities to market players.

Illumina, Inc. announced the release of TruSightTM Oncology (TSO) Comprehensive on March 15, 2022, a single test that examines numerous tumor genes and biomarkers to determine a patient's cancer molecular profile.
PathSensors Inc. developed the CANARY biosensor to identify the novel SARS coronavirus, which was ready for study by May 2020.

The laboratory developed test market has seen a surge in agreements, product launches, and approvals, as well as acquisitions & collaborations, as industry players are seeking to expand their geographical presence and product offerings. Key businesses are concentrating their efforts on gaining local talent and forming partnerships with large domestic suppliers.

Competitive Landscape

Acquisitions, product launches, and collaborations are among some of the approaches used by leading developers and manufacturers of laboratory developed tests to enhance their presence in the global market, resulting in increased customer bandwidth for manufacturers.

In May 2022, Epic Sciences, Inc. announced the launch of DefineMBC™, a novel comprehensive blood-based test for distinguishing metastatic breast cancer. This test will provide both cell-based and cell-free analysis from a single blood draw to provide comprehensive profiling in the absence of a tissue biopsy result.
In January 2022, 23andMe announced FDA clearance for a direct-to-consumer genetic test on a hereditary prostate cancer marker.
Roche launched the AVENIO Edge System, in December 2021, which simplifies and automates sample preparation for next-generation sequencing, reducing human error and advancing precision medicine.
Adaptive Biotechnologies opened a new corporate headquarters in Seattle's South Lake Union in September 2021.

Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/3430

Key Takeaways

By test type, clinical biochemistry tests held the highest market share of 33.5% by value in 2021.
Oncology accounted for the highest market share under application at 41.2% in 2021.
By end user, hospital laboratories are preferred by patients, and the segment held a market share of around 48.7% in 2021.
Around 35.7% of the global market share was accounted for by North America in 2021.

"Better prospects for enterprises to enter the market as a result of more CLIA product approvals and collaborations will benefit the laboratory developed test industry over the coming years," says an analyst of Persistence Market Research.

 Key Questions Answered in This Report.

What are the Roadblocks for Laboratory Developed Testing Suppliers?
What are the Key Opportunities for Laboratory Developed Testing Manufacturers?
How is Focus on Safety Influencing Laboratory Developed Testing Demand?
What is the Regulatory Impact on Global Sales of Laboratory Developed Testing?
Which Region Offers the Largest Opportunity for Sales of Laboratory Developed Testing?
Where Does the U.S. Stand in the Market for Laboratory Developed Testing?
What Is the Outlook for Laboratory Developed Testing Manufacturers in China?
Why is Germany a Lucrative Market for Laboratory Developed Testing Manufacturers?
Why Will Belgium Outpace Other European Markets for Laboratory Developed Testing?
Why is There High Demand for Tires in Laboratory Developed Testing?
Why are Sales of Laboratory Developed Testing Surging?

Request Customization @ https://www.persistencemarketresearch.com/request-customization/3430

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.